These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 1037266

  • 21. The effect of precursors of noradrenalin on the response to tyramine and sympathetic stimulation.
    BURN JH, RAND MJ.
    Br J Pharmacol Chemother; 1960 Mar; 15(1):47-55. PubMed ID: 13806188
    [Abstract] [Full Text] [Related]

  • 22. The action of protriptyline on peripheral autonomic function.
    Cairncross KD, McCulloch MW, Mitchelson F.
    J Pharmacol Exp Ther; 1965 Sep; 149(3):365-72. PubMed ID: 5848047
    [No Abstract] [Full Text] [Related]

  • 23. General pharmacological profile of the new cognition-enhancing agent nefiracetam.
    Kitano Y, Makino M, Usui C, Takasuna K, Kasai Y, Hirohashi M, Tamura K, Takayama S, Kojima H, Iizuka H.
    Arzneimittelforschung; 1994 Feb; 44(2A):199-210. PubMed ID: 8018090
    [Abstract] [Full Text] [Related]

  • 24. Centrally mediated release by cocaine of endogenous epinephrine and norepinephrine from the sympathoadrenal medullary system of unanesthetized rats.
    Chiueh CC, Kopin IJ.
    J Pharmacol Exp Ther; 1978 Apr; 205(1):148-54. PubMed ID: 633079
    [Abstract] [Full Text] [Related]

  • 25. Cocaine: cardiovascular effects in relation to inhibition of peripheral neuronal monoamine uptake and central stimulation of the sympathoadrenal system.
    Tella SR, Schindler CW, Goldberg SR.
    J Pharmacol Exp Ther; 1993 Oct; 267(1):153-62. PubMed ID: 8229742
    [Abstract] [Full Text] [Related]

  • 26. General pharmacological properties of the main metabolite of flosequinan.
    Fujita S, Ikezono K, Umezato M, Hosoki E, Toba Y, Ishikawa M, Kusunoki A, Shintani S.
    Arzneimittelforschung; 1992 Oct; 42(10):1212-22. PubMed ID: 1335257
    [Abstract] [Full Text] [Related]

  • 27. [Tyramine tachyphylaxis; its recovery and interaction with enzyme inhibitors in arterial pressure and cat nictitating membrane].
    Lorenzo Fernandez P, Moreno A, Mediavilla A, Navas J.
    Arch Inst Farmacol Exp (Madr); 1969 Oct; 21(1):11-42. PubMed ID: 4328437
    [No Abstract] [Full Text] [Related]

  • 28. Pharmacological actions of the antihypertensive agent N-amidino-2-(2,6-dichlorophenyl)acetamide hydrochloride (BS 100-141).
    Scholtysik G, Lauener H, Eichenberger E, Bürki H, Salzmann R, Müller-Schweinitzer E, Waite R.
    Arzneimittelforschung; 1975 Oct; 25(10):1483-91. PubMed ID: 1243025
    [Abstract] [Full Text] [Related]

  • 29. THE RESPONSES TO TYRAMINE OF THE NORMAL AND DENERVATED NICTITATING MEMBRANE OF THE CAT: ANALYSIS OF THE MECHANISMS AND SITES OF ACTION.
    HAEFELY W, HUERLIMANN A, THOENEN H.
    Br J Pharmacol Chemother; 1963 Aug; 21(1):27-38. PubMed ID: 14066148
    [Abstract] [Full Text] [Related]

  • 30. [On relations between the distribution of electrons in monoguanylhydrazones and their pharmacological action].
    Mutschler E, Scherf H, Voss P, Wassermann O.
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1967 Aug; 256(3):367-82. PubMed ID: 4231693
    [No Abstract] [Full Text] [Related]

  • 31. Inhibition of sympathetic nervous system by mexiletine, an antiarrhythmic agent, and its antagonism against ouabain.
    Kitagawa H, Takeda F, Kohei H.
    Arzneimittelforschung; 1985 Aug; 35(1A):356-9. PubMed ID: 4039173
    [Abstract] [Full Text] [Related]

  • 32. Mechanism of cardiovascular actions of heptanolamines.
    GARRETT J, OSSWALD W, GONCALVES MOREIRA M.
    Br J Pharmacol Chemother; 1962 Feb; 18(1):49-60. PubMed ID: 13897064
    [Abstract] [Full Text] [Related]

  • 33. [Cardiovascular effects of (+)- and (-)-tranylcypromine compared to other monoamine oxidase inhibitors in animal studies (author's transl)].
    Dénes B, Greeff K, Tawfik H.
    Arzneimittelforschung; 1982 Feb; 32(3):201-7. PubMed ID: 6805481
    [Abstract] [Full Text] [Related]

  • 34. Some cocaine-like actions of 3-phenoxypro-pylguanidine.
    BARTLET AL.
    Br J Pharmacol Chemother; 1962 Jun; 18(3):475-89. PubMed ID: 13865441
    [Abstract] [Full Text] [Related]

  • 35. Chemical sympathectomy of the cat with 6-hydroxydopamine.
    Haeusler G, Haefely W, Thoenen H.
    J Pharmacol Exp Ther; 1969 Nov; 170(1):50-61. PubMed ID: 5351006
    [No Abstract] [Full Text] [Related]

  • 36. Norepinephrine depletion and sensitivity changes in rat heart induced by pretreatment with reserpine.
    Rice PJ, Taylor DA, Valinski WA, Head RJ, Fleming WW.
    J Pharmacol Exp Ther; 1987 Mar; 240(3):764-71. PubMed ID: 3559972
    [Abstract] [Full Text] [Related]

  • 37. Co-release and functional interactions of neuropeptide Y and noradrenaline in peripheral sympathetic vascular control.
    Pernow J.
    Acta Physiol Scand Suppl; 1988 Mar; 568():1-56. PubMed ID: 3232527
    [Abstract] [Full Text] [Related]

  • 38. [Pharmacology of diphenylalkyl-derivatives. IV. Pharmacology of a noradrenaline increasing effect of dephenylpropylamine-amine-derivatives].
    Leszkovszky GP, Tardos L, Lendvai J, Takács K.
    Arzneimittelforschung; 1967 Dec; 17(12):1590-5. PubMed ID: 5633110
    [No Abstract] [Full Text] [Related]

  • 39. Preparation and pharmacological activity of the condensation product of adrenaline with acetaldehyde.
    Osswald W, Polónia J, Polónia MA.
    Naunyn Schmiedebergs Arch Pharmacol; 1975 Dec; 289(3):275-90. PubMed ID: 1161056
    [Abstract] [Full Text] [Related]

  • 40. [Mechanism of the inotropic action of heptaminol on heart muscle].
    Reiter M.
    Naunyn Schmiedebergs Arch Pharmakol; 1970 Dec; 266(4):433-4. PubMed ID: 4253856
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.